2025 annual financial data

Protara Therapeutics 2025 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -64.55M USD and net income was -57.44M USD.
Operating cash flow was -56.37M USD.

Get free Protara Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-64.55M USD
Net income
-57.44M USD
Operating cash flow
-56.37M USD